Co-Diagnostics, Inc. - CODX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 11, 2026 SCHEDULE 13G/A Ayrton Capital LLC 0.0% 0 View
Feb 11, 2026 SCHEDULE 13G/A Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B 0.0% 0 View
Feb 11, 2026 SCHEDULE 13G/A Waqas Khatri 0.0% 0 View
Nov 13, 2025 SCHEDULE 13G Ayrton Capital LLC 9.7% 3,738,327 View
Nov 13, 2025 SCHEDULE 13G Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B 9.7% 3,738,327 View
Nov 13, 2025 SCHEDULE 13G Waqas Khatri 9.7% 3,738,327 View
Oct 30, 2025 SCHEDULE 13G/A Orca Capital AG 3.7% 2,248,182 View
Oct 30, 2025 SCHEDULE 13G/A The Vanguard Group 3.54% 1,705,952 View
Oct 30, 2025 SCHEDULE 13G/A Orca Capital AG 9.9% 6,001,135 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.